Napsin A as a key prognostic biomarker in spinal metastases of lung cancer: implications for survival and neurological function.
Napsin A as a key prognostic biomarker in spinal metastases of lung cancer: implications for survival and neurological function. Neurosurg Focus. 2025 May 01; 58(5):E18.